


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:49:00Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405321" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405321</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eat Weight Disord</journal-id><journal-id journal-id-type="iso-abbrev">Eat Weight Disord</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>Eating and Weight Disorders</journal-title></journal-title-group><issn pub-type="ppub">1124-4909</issn><issn pub-type="epub">1590-1262</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405321</article-id><article-id pub-id-type="pmcid-ver">PMC12405321.1</article-id><article-id pub-id-type="pmcaid">12405321</article-id><article-id pub-id-type="pmcaiid">12405321</article-id><article-id pub-id-type="pmid">40892275</article-id><article-id pub-id-type="doi">10.1007/s40519-025-01784-7</article-id><article-id pub-id-type="publisher-id">1784</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Post-bariatric surgery quality-of-life decline: analysis of the gut&#8211;brain axis</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Jiao</surname><given-names initials="Y">Yuxuan</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Zhu</surname><given-names initials="S">Shaohui</given-names></name><address><email>Shaohui912@126.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xue</surname><given-names initials="H">Huichao</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="Y">Yihao</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="Y">Yanfang</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hou</surname><given-names initials="D">Dong</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04wjghj95</institution-id><institution-id institution-id-type="GRID">grid.412636.4</institution-id><institution>The Department of General Surgery, </institution><institution>First Affiliated Hospital of Henan Medical University, </institution></institution-wrap>Xinxiang City, Henan Province China </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>30</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">496088</issue-id><elocation-id>73</elocation-id><history><date date-type="received"><day>15</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>24</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="40519_2025_Article_1784.pdf"/><abstract id="Abs1"><sec><title>Purpose</title><p id="Par1">Bariatric surgery has proven effective in enhancing metabolic health and achieving sustainable weight loss for individuals with obesity. However, some patients experience adverse psychological outcomes and reduced quality-of-life post-surgery, potentially linked to&#160;changes in the gut&#8211;brain axis. This review aims to synthesize current evidence on the interplay between bariatric surgery-induced gut&#8211;brain axis modifications and patients&#8217; psychological status.</p></sec><sec><title>Methods</title><p id="Par2">A systematic literature search was conducted across PubMed, Web of Science, and Embase, prioritizing clinical studies, mechanistic investigations, and meta-analyses. Inclusion criteria encompassed English-language articles examining psychological parameters, gut-derived hormones, and gut microbiota in adults after Roux-en-Y gastric bypass or sleeve gastrectomy.</p></sec><sec><title>Results</title><p id="Par3">Bariatric surgery fundamentally reprograms gut&#8211;brain communication through anatomical, endocrine, and neural plasticity mechanisms, a process associated with dual-edged metabolic benefits and neuropsychiatric risks. Mechanistic analyses suggest that postoperative dysregulation of GLP-1/PYY secretion, altered vagal afferent signaling, and sustained microbiota dysbiosis (reduced Bifidobacterium, elevated Proteobacteria) may represent potential correlates of these outcomes.</p></sec><sec><title>Conclusions</title><p id="Par4">Studies have demonstrated significant associations between mood, quality of life, psychological status, and gut-derived hormones or microbiota.&#160;A comprehensive understanding of how bariatric surgery impacts gut&#8211;brain signaling pathways is critical for optimizing long-term therapeutic outcomes and enhancing patient quality of life.</p></sec><sec><title>Level of evidence</title><p id="Par5">This manuscript is a Narrative Review. According to the grading criteria of the Oxford Centre for Evidence-Based Medicine (OCEBM), this manuscript is categorized as Level III&#8211;IV evidence.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Bariatric surgery</kwd><kwd>Gut&#8211;brain axis</kwd><kwd>Quality of life</kwd><kwd>Mental health</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Switzerland AG 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par6">Obesity, a chronic metabolic disease, is characterized by excessive accumulation and/or abnormal distribution of body fat, leading to increased body weight, resulting from the interaction of various factors, including genetics and environment [<xref ref-type="bibr" rid="CR1">1</xref>]. Based on statistics provided by the World Health Organization (WHO), the prevalence of obesity worldwide has been tripling since 1975, becoming a global public health challenge. Obesity is tightly linked to a range of medical disorders, including metabolic syndrome (including abdominal obesity, hyperglycemia, hyperlipidemia, hyperuricemia), heart and blood vessel diseases (concerning high blood pressure, coronary artery disease, stroke, arteriosclerosis), respiratory diseases (such as asthma and sleep apnea syndrome), and certain types of cancer. In addition, obese patients are prone to psychological disorders, such as low self-esteem, depression, and anxiety, potentially linked to a decline in quality of life. They are also susceptible to neurological diseases (e.g., stroke, dementia, Parkinson&#8217;s disease) as well as mental/psychiatric conditions including sleep disorders. In short, diseases related to obesity cover almost all organs of the body and the field of mental health [<xref ref-type="bibr" rid="CR2">2</xref>&#8211;<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par7">With the continuous rise in global obesity rates, bariatric surgery for treating obesity-related diseases has become an urgent need in clinical research. The success of the first bariatric surgery in the 1950s marked the beginning of a progressive era in surgical weight management. With the continuous advancement of bariatric surgery techniques, procedures such as Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) have demonstrated their efficacy in markedly enhancing the metabolic health of patients with obesity and in achieving sustainable weight loss. Moreover, RYGB and SG, especially the latter, have low complication rates. As a result, bariatric surgery has been rapidly promoted worldwide. According to the American Society for Metabolic and Bariatric Surgery (ASMBS), in 2020, Laparoscopic Sleeve Gastrectomy (LSG) accounted for 62% of all the bariatric operations conducted in the United States and about 85% in China, making it the most common method of bariatric surgery. Nowadays, bariatric surgery has been acknowledged as an effective intervention for treating obesity and its accompanying comorbidities. It can not only significantly reduce body weight but also improve or cure a variety of obesity-associated diseases, such as type 2 diabetes, high blood pressure, and sleep apnea. The New England Journal of Medicine reported on a study indicating that 75% of individuals undergoing gastric bypass surgery achieved successful regulation of their diabetes within a 2-year timeframe following the procedure [<xref ref-type="bibr" rid="CR5">5</xref>]. In addition, bariatric surgery also promotes mental well-being and improves the life quality for patients. However, for some people who have undergone bariatric surgery, their quality of life not only does not improve after surgery but also declines.</p><p id="Par8">The phenomenon of decreased quality of life has attracted widespread attention in the medical community. Researchers have begun to delve into and study the potential mechanisms behind the decline in post-bariatric surgery life quality, among which the role of the gut&#8211;brain axis has gradually emerged, becoming a subject of intense research interest. The gut&#8211;brain axis represents the bidirectional communication link between the gut and the brain&#8217;s central nervous system. The operation of this axis involves the interaction of neural transmission, hormone secretion, and the gut microbiome, which collectively impact various physiological and psychological processes in the human body. The notion of the gut&#8211;brain axis offers a fresh outlook for evaluating the impact of bariatric surgery on life quality [<xref ref-type="bibr" rid="CR6">6</xref>]. After bariatric surgery, changes in the function and anatomical structure of the digestive tract are associated with alterations in the normal operation of the gut&#8211;brain axis, which may in turn be linked to changes in&#160;patients&#8217; emotions, quality of life, and behavior. A retrospective meta-analysis involving 32 quality-of-life-related items or measures indicates that compared to the control group, post-operative bariatric patients have a significantly higher likelihood of experiencing psychological issues, including substance use disorders, emotional fluctuations, anxiety, and even depression, which researchers suggest may be associated with imbalance of the gut&#8211;brain axis [<xref ref-type="bibr" rid="CR7">7</xref>].As research continues to delve deeper, more and more evidence shows that considering the neuroendocrine changes of the gut&#8211;brain axis as a candidate for exploring associations between bariatric surgery and reduced life quality is logical. In light of this, this review, against the backdrop of the two main types of bariatric surgery, provides an in-depth analysis of the gut&#8211;brain axis&#8217;s role in the reduction of life quality after gastric surgery.</p></sec><sec id="Sec2"><title>The operational mechanisms of RYGB and sleeve gastrectomy</title><p id="Par9">RYGB surgery divides the patient&#8217;s stomach into upper and lower parts, creating a small-capacity gastric pouch (15&#8211;30&#160;ml) at the junction, where the esophagus meets the stomach. The pouch is then connected to the lower part of the small intestine, or jejunum, which allows food to bypass the rest of the stomach and the initial portion of the small intestine. To reestablish the flow of the digestive system and to enable the mixing of bile and pancreatic juices with the food in the jejunum, a second anastomosis is created between two parts of the jejunum, located 100&#8211;150&#160;cm away from the point, where the small intestine is joined to the gastric pouch. Sleeve gastrectomy involves placing a 32&#8211;40 Fr calibrating gastric tube into the stomach through the mouth, typically starting the resection 2&#8211;6&#160;cm away from the pylorus, following the calibrating gastric tube closely and moderately taut, cutting continuously towards the gastric fundus until the fundus is transected 0.5&#8211;1&#160;cm from the His angle. Subsequently, the gastric resection margin is reinforced from the fundus to the pylorus [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. After this surgery, the remaining stomach volume of the patient is approximately 100&#160;ml. Both bariatric surgery methods achieve weight loss by reducing stomach volume, limiting food intake, decreasing the rate of food absorption, and slowing the speed of eating. However, studies on adjustable gastric banding have found that even when the postoperative gastric pouch volume is controlled at 30&#160;ml, its weight loss effect is still not as significant as that of sleeve gastrectomy. This research result implies that the reduction in stomach capacity is not the only factor contributing to decreased energy intake and weight loss.</p><p id="Par10">The gastrointestinal tract&#8217;s feedback regulation of the brain&#8217;s appetite center also has an essential function. In the gut&#8211;brain axis&#8217;s appetite regulation pathways, ghrelin is recognized as the primary hormone possessing appetite-stimulating properties, chiefly released by the P/D1 cells in the gastric fundus and the &#949; cells in the pancreas. Notably, these cell groups are located in the surgical resection area of sleeve gastrectomy. After bariatric surgery, the decline in ghrelin levels is not the only significant change in gut hormones. Glucagon-like peptide-1(GLP-1) and peptide YY (PYY) are also two representative hormones, the concentrations of which are significantly increased after surgery.GLP-1 increases sharply after meals and reaches its peak within 15&#8211;30&#160;min. It delays the digestion and absorption process of food by inhibiting gastric emptying and reducing food intake. At the same time, it can effectively mitigate postprandial hyperglycemia. The production of PYY is similar to GLP-1; 15&#160;min after eating, the ileal L cells begin to secrete PYY, but in such a short time, the chyme has not yet reached the ileum. This phenomenon indicates that the ileal L cells do not produce related hormones under the direct action of chyme but rely on other neuroendocrine regulatory mechanisms. PYY triggers responses by acting on the Y2 receptors of the NPY family. The Y2 receptors are scattered widely across the peripheral and central nervous systems, with a pronounced concentration in the arcuate nucleus of the hypothalamus, considered the central domain for hunger regulation. However, changes in gut hormones may be associated with fluctuations in mood and cognitive functions, such as increased anxiety and depressive symptoms, the occurrence of substance use disorders, and declines in memory and attention [<xref ref-type="bibr" rid="CR10">10</xref>].</p><p id="Par11">In addition, bariatric surgery not only is associated with changes in gastrointestinal hormones but also is linked to alterations in the intestinal flora. Clinical studies have demonstrated that after bariatric surgery, the diversity of gut bacteria decreases, but it is often the beneficial flora, such as Lactobacillus and Bifidobacterium, that exhibit reduced abundance, while pathogenic potential micro-organisms, particularly, Proteobacteria and Bacteroidetes, increase in abundance. Such transformations are connected to weight reduction and optimized metabolic activity, and at the same time, they are linked to variations in intestinal barrier and immune responses. Such shifts in the gut microbiota may be associated with changes in the local intestinal environment; meanwhile, they may also be linked to alterations in brain function via the gut&#8211;brain axis, and these changes may in turn be related to modifications in psychological states, behaviors, and quality of life [<xref ref-type="bibr" rid="CR10">10</xref>]. This process once again confirms that the delicate balance within the body and its complex interactions far exceed our traditional understanding of physiological mechanisms.</p></sec><sec id="Sec3"><title>The gut&#8211;brain axis and its mechanistic effects on quality of life</title><p id="Par12">The intestines, the longest organ within the human body, have their own dedicated nervous system, referred to as the Enteric Nervous System (ENS), which contains about 500 million neurons, comparable in number to those in the brain, forming what is known as "second brain." The ENS connects with the central nervous system through various pathways, including the ENS, the vagus nerve, the endocrine system, and the intestinal microbiota, forming the gut&#8211;brain axis. Post-bariatric surgery, alterations in the gastrointestinal tract&#8217;s anatomy and functionality are closely associated with changes in the back-and-forth communication of the gut&#8211;brain link. Taking RYGB as an example, this surgery reduces food intake and intestinal absorption area by shrinking stomach capacity and altering the route through which food bypasses the small intestine, thereby affecting food digestion and absorption. Studies have shown that patients who undergo RYGB may attain a mean weight loss of 30&#8211;40% of their original weight and significantly alleviate health risks associated with obesity, including type 2 diabetes, high blood pressure, and sleep apnea [<xref ref-type="bibr" rid="CR5">5</xref>]. However, alterations in the intestinal architecture are associated with modifications to the neuroendocrine system and the gut microbiota, which in turn are linked to direct or indirect changes in brain function and emotional states, and these changes may be associated with negative impacts on patients&#8217; quality of life. Therefore, in-depth analyses of the physiological mechanisms of the gut&#8211;brain axis is crucial for developing interventions aimed at reducing the decline in quality of life and adverse mental health outcomes following post-bariatric surgery.</p><sec id="Sec4"><title>Impact of the gut microbiota</title><p id="Par13">The gut microbiota, which constitutes the normal microbial ecosystem within the human gut, can be broadly categorized into three groups: beneficial bacteria, harmful bacteria, and neutral bacteria. The number of these micro-organisms reaches approximately 10<sup>^14</sup>, encompassing 500&#8211;1000 different microbial species. They are necessary agents in the food digestion and nutrient absorption process, defense against infections, control of the risk of autoimmune diseases, and regulation of the body&#8217;s response to cancer treatments. In the healthy adult&#8217;s intestinal microbiota, Firmicutes and Bacteroidetes account for up to 90% of the composition [<xref ref-type="bibr" rid="CR11">11</xref>]. The balance of the gut microbiota is closely associated with the stability of the gut&#8211;brain axis. Disruption of this balance is associated with a decline in human health status. For instance, Studies have shown that a higher Firmicutes-to-Bacteroidetes ratio is correlated with the occurrence of obesity, and it has been reported that in obese populations, the gut microbiota exhibits reduced diversity and species richness [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par14">Following bariatric surgery, the structure of the gut microbiota undergoes significant changes, specifically, there is an increase in the relative abundance of Proteobacteria and Bacteroidetes, while the relative abundance of Firmicutes and Bifidobacterium decreases [<xref ref-type="bibr" rid="CR14">14</xref>]. These alterations can persist for up to 9 years in humans [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Over the past decades, the potential for gut microbiota to affect organs and their functions beyond the gastrointestinal system is a hot topic in the field of medical research. Studies have indicated that germ-free mice, which lack a balanced gut microbiota, exhibit abnormalities during early development in phenotype and neurochemistry, implying that the gut microbiota might affect quality of life and mental health; these abnormalities can be corrected by restoring a normal gut microbiota [<xref ref-type="bibr" rid="CR16">16</xref>]. For instance, compared to healthy controls, patients exhibiting depression and anxiety have been found to have a reduced relative abundance of Firmicutes and an increased relative abundance of Bacteroidetes. This phenomenon suggests that the observed gut microbiota characteristics may be associated with the occurrence of depression and anxiety symptoms in some post-bariatric surgery patients, despite the lack of complete clarity on the mechanisms involved. However, through experimental manipulation of the gut microbiota composition or its metabolic byproducts, changes in the behavioral and physiological characteristics of rodents in depression models can be observed [<xref ref-type="bibr" rid="CR17">17</xref>]. Further research has shown that transplanting fecal microbiota from depressed men into rats administered antibiotics or into germ-free mice causes the recipients to exhibit anhedonia, anxiety, and depressive behaviors [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>].</p><p id="Par15">The rodent models have shown that manipulating the gut microbiota&#8217;s composition and metabolic outputs can significantly alter depressive and anxious behaviors, providing a solid experimental foundation for investigating the influence of gut bacteria on mental health. However, when extending the study findings to humans, the mechanisms by which the gut microbiota influences emotional states still demand deeper research for more conclusive proof. Nevertheless, this does not mean that there is a lack of empirical data to underpin this perspective. Multiple case&#8211;control studies between healthy individuals and those with depression and anxiety have provided support for an association between gut microbiota and mental health. For instance, the supplementation of probiotics, specifically, Bifidobacterium and Lactobacillus strains, when used to modulate the gut microbiota, can alleviate symptoms of anxiety and depression, lower cortisol levels, and reduce the amygdala&#8217;s reactivity to fear-inducing stimuli [<xref ref-type="bibr" rid="CR20">20</xref>].</p><p id="Par16">The research on the correlation between variations in gut microbiota composition and function and emotional states following bariatric surgery in humans still requires further in-depth exploration. However, with the continuous advancement of technology, we have ample reason to believe that by precisely regulating the gut microbiota, we can substantially elevate the health conditions and life quality for individuals who have undergone bariatric surgery.</p></sec><sec id="Sec5"><title>Impact of gut endocrine hormones on mood</title><p id="Par17">The gut endocrine cells, distributed within the mucosal layer of the gastrointestinal system, can sense mechanical, chemical, and neural stimuli within the lumen, including food intake, nutrient absorption, and contact with microbial byproducts. In response to these stimuli, these cells release multiple hormones and peptides that can influence neighboring intestinal cells (paracrine), disperse into the bloodstream via the lamina propria (endocrine), or activate the vagus nerve and sensory nerve fibers that innervate the intestinal wall and the enteroendocrine cells (neural), thereby producing systemic effects [<xref ref-type="bibr" rid="CR21">21</xref>]. The various hormones and peptides secreted by enteroendocrine cells, such as GLP-1, ghrelin, PYY, and cholecystokinin (CCK), are crucial in regulating appetite and energy balance. Although SG and RYGB surgery have significant differences in anatomical structure, both can significantly reduce food intake, body mass, and glycemic levels, and there are some similarities in the circulating levels of enteroendocrine hormones. For example, both types of surgery can stimulate the release of a range of satiety hormones in response to food, including GLP-1, PYY, and CCK. These hormones not only act within the intestine but also transmit signals to the CNS via the gut&#8211;brain axis, which in turn impacts mood, quality of life, and cognitive performance [<xref ref-type="bibr" rid="CR22">22</xref>].</p><p id="Par18">L cells at the ileum&#8217;s extremity secrete GLP-1, and its functions include enhancing satiety, attenuating the rate of gastric emptying, and inhibiting intestinal motility. Post-bariatric surgery, GLP-1 concentrations undergo a substantial rise, thereby contributing to rapid weight loss. In addition, the GLP-1 receptor(GLP1-R)is abundantly present in areas of the brain that are directly tied to stress, reward, and mood regulation, including the paraventricular nucleus of the hypothalamus (PVN), the ventral tegmental area(VTA),the amygdala, and the hippocampus. This neural reflex pathway indicates that GLP-1 may play a potential part in regulating stress responses. Studies in rodent models have confirmed that GLP-1&#160;is associated with changes in&#160;depressive and anxiety behaviors, but its effects are not constant. For example, a single dose of a peripheral GLP-1 receptor agonist before the forced swim test does not induce changes in depressive-like behaviors in mice; however, after continuous administration for 1&#8211;2&#160;weeks, the agonist shows antidepressant-like effects [<xref ref-type="bibr" rid="CR23">23</xref>]. In rats, however,&#160;a one-time central or peripheral application of a GLP-1 receptor agonist can cause anxiety-like behaviors, while chronic central administration does not modify anxiety or depressive-like behaviors [<xref ref-type="bibr" rid="CR24">24</xref>].Clinical trials likewise demonstrate that intravenous injection of GLP-1 and its receptor agonists do not produce an anxiety-inducing effect in both healthy control groups and patients with panic disorder [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>].These research results reveal the complexity of gut hormones in the modulation of mood and quality of life,&#160;suggesting that when assessing and improving post-bariatric surgery life quality, we need to consider the dynamic effects of these biomolecules. At the same time, in-depth research on the mechanisms of GLP-1 and its receptor in mood regulation might introduce new biological markers for the intervention of psychological illnesses, such as depression and anxiety.</p><p id="Par19">P/D1 cells in the fundus of the stomach and epsilon cells in the pancreas are the main sites of Ghrelin secretion. As an endogenous hormone, its role is to enhance hunger and intestinal motility, increase food intake, and thereby promotes weight gain. Ghrelin levels significantly decrease after bariatric surgery, and this may have a potential link with fluctuations in patients&#8217; life quality postoperatively. In rodents, extensive research has explored the impact of ghrelin administration or blockade on anxiety and depressive behaviors, but these results are modulated by various factors, such as the external environment, timing, route of administration, dosage, and duration. For example, in rat experiments, if food is given within an hour after injecting ghrelin and before the behavioral test, the anxiolytic effect of ghrelin on the amygdala will no longer exist [<xref ref-type="bibr" rid="CR27">27</xref>]. This result suggests that under conditions, where food is not accessible, amygdala ghrelin communication may be associated with the inhibition of anxiety-like responses. However, in ghrelin gene knockout mouse models, anxiety effects under acute stress are enhanced, while anxiety-like behaviors are reduced under non-stress conditions [<xref ref-type="bibr" rid="CR28">28</xref>].Nonetheless, most rodent studies support an association between acute/chronic exposure to ghrelin, whether produced internally or externally, and antidepressant-like outcomes [<xref ref-type="bibr" rid="CR29">29</xref>&#8211;<xref ref-type="bibr" rid="CR31">31</xref>]. However, in clinical experiments, the correlation between ghrelin and emotional states has not been fully confirmed, and its specific mechanisms of action and clinical applications still require further in-depth exploration.</p><p id="Par20">PYY&#160;secreted by L cells at the end of the ileum and belonging to the NPY neuropeptide family, significantly increases in secretion levels after bariatric surgery and activates NPY receptor subtypes. NPY along with its receptor types are extensively present across different areas of the brain, including the hippocampus, amygdala, the hypothalamic arcuate nucleus, and the nucleus accumbens [<xref ref-type="bibr" rid="CR32">32</xref>]. The hippocampus, amygdala, and nucleus accumbens play key roles in the body&#8217;s stress response and emotional regulation, suggesting that PYY can influence emotions and behavior by acting on these brain areas. In fact, human studies on NPY expression or genetic variations also underscore the role of the NPY family in regulating emotional and behavioral states, particularly highlighting NPY&#8217;s anxiolytic properties [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>].</p><p id="Par21">Bile acids, as key components of bile, are the ultimate products of cholesterol metabolism in the liver. In human physiology, bile acids play multiple crucial functions, including promoting the digestion and absorption of fats, maintaining cholesterol homeostasis, and stimulating the pancreas to secrete pancreatic juice. In particular, bile acids, beyond their function in fat metabolism, glucose metabolism, lipid and energy balance, may also affect emotional states. Notably the Farnesoid X receptor(FXR),as a bile acid receptor, is highly expressed in both&#160;the liver and intestine, as well as in the neurons of the cerebral cortex and hippocampus [<xref ref-type="bibr" rid="CR35">35</xref>].Animal experimental results show that mice and rats with FXR gene deficiency exhibit abnormal neurobehavioral and biochemical indicators, such as reduced depression-like and anxiety-like behaviors, as well as a drop in brain-derived neurotrophic factor (BDNF) expression [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. However, such research has not been fully conducted in the field of clinical experiments; therefore, studying the impact of bile acids on emotional regulation after bariatric surgery presents certain difficulties.</p><p id="Par22">CCK is synthesized from 33 amino acids and was initially extracted from the proximal small intestine, subsequently located in several brain regions, among them the cerebral cortex, hippocampus, amygdala, hypothalamus, and ventral tegmental area [<xref ref-type="bibr" rid="CR38">38</xref>].To date, the peripheral effects of CCK have been extensively studied. Cholecystokinin can promote gastric acid and bile secretion, and at the same time, it curbs sodium absorption in the ileum and water absorption process, and stimulates the release of insulin and glucagon. In addition, substances such as protein breakdown products, fatty acid salts, and hydrochloric acid can stimulate the secretion of CCK, which in turn continuously transmits satiety signals to the hypothalamus, suppressing the generation of appetite. CCK not only acts on the hypothalamus but also affects regions in the cerebral cortex and limbic system that participate in emotional responses and regulation, including the amygdala, hippocampus, and VTA. In human studies, intravenous infusion of cholecystokinin tetrapeptide (CCK4) can induce panic attacks in those suffering from anxiety disorders and healthy individuals [<xref ref-type="bibr" rid="CR39">39</xref>]. However, this outcome can be prevented by pre-administering CCKR2 antagonists [<xref ref-type="bibr" rid="CR39">39</xref>&#8211;<xref ref-type="bibr" rid="CR41">41</xref>].It is worth noting that long-term use of CCK antagonists in humans (for more than 4&#8211;6&#160;weeks) has not improved symptoms of anxiety or panic disorders [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>],but the use of anti-anxiety drugs can effectively reduce individuals&#8217; sensitivity to CCK4-induced panic effects. This phenomenon indicates that CCK&#8217;s role in anxiety is influenced by its engagement with other biological signaling pathways [<xref ref-type="bibr" rid="CR44">44</xref>].</p></sec><sec id="Sec6"><title>The impact of gut endocrine hormones on addictive behaviors</title><p id="Par23">After bariatric surgery, gut endocrine hormones not only affect mood and psychological status but also involve the regulation of addictive behaviors. Researchers have begun to pay attention to the fact that patients after bariatric surgery may seek rewards in other areas to compensate for the psychological void brought about by a decrease in food eaten. Studies have shown that these hormones can act on the brain&#8217;s reward system,&#160;which may be associated with alterations in an individual&#8217;s dependence on substances, such as food, drugs, nicotine, or alcohol. The regulation of the reward system covers both the intake of food and drugs and is also related to an individual&#8217;s behavioral patterns and social activities [<xref ref-type="bibr" rid="CR45">45</xref>]. Accumulating evidence reveals an increased risk of alcohol use disorders following RYGB and SG [<xref ref-type="bibr" rid="CR46">46</xref>],and there may also be issues with the use of other drugs(especially opioids) [<xref ref-type="bibr" rid="CR47">47</xref>&#8211;<xref ref-type="bibr" rid="CR49">49</xref>].In addition, some case reports have revealed new cognitive behavioral conditions in patients, for instance, gambling or shopping addiction. The "addiction transfer" hypothesis has been proposed, suggesting that someone might cultivate a new" addictive" behavior instead of the&#160;satisfaction and pleasure brought by preoperative eating [<xref ref-type="bibr" rid="CR50">50</xref>]. However, at present, this hypothesis lacks scientific basis.</p><p id="Par24">Interestingly, initially, research on the postoperative effects of bariatric surgery on alcohol use disorders showed a positive effect, with a decrease in both the desire for and consumption of alcohol [<xref ref-type="bibr" rid="CR51">51</xref>]. However, as research on bariatric surgery continues to delve deeper, approximately 50% of patients halted their alcohol-seeking behavior in the first year subsequent to RYGB. After the initial year, a boost in alcohol consumption and the incidence of alcohol use disorders was noted from the second year, with these rates remaining high for several years after RYGB [<xref ref-type="bibr" rid="CR52">52</xref>].Numerous studies corroborate this finding, indicating that RYGB has led to an increase in alcohol intake among patients who had a lower baseline alcohol intake before surgery [<xref ref-type="bibr" rid="CR52">52</xref>&#8211;<xref ref-type="bibr" rid="CR54">54</xref>].</p><p id="Par25">Patients are at risk of developing substance use disorders after bariatric surgery, and in cases of drug abuse treatment, a disproportionately high proportion of patients are those who have had bariatric surgery [<xref ref-type="bibr" rid="CR54">54</xref>].Alarmingly, many of the substance use disorders that emerge postoperatively are new occurrences [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>].Research on individuals who had bariatric surgery and later joined inpatient substance abuse rehabilitation found that over 50% had no prior substance use [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>].This leads us to ponder whether there is a correlation between bariatric surgery and changes in cognitive behavior.</p><p id="Par26">Studies to date have indicated that central ghrelin signaling may be a potential mechanism for changes in alcohol reward following RYGB [<xref ref-type="bibr" rid="CR58">58</xref>].In studies on rodents, food and alcohol seeking behaviors are mediated by central ghrelin signaling at the growth hormone secretagogue receptor(GHSR) within the VTA [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>].This mechanism could explain the changes in alcohol consumption and/or reward mechanisms observed after RYGB [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. Furthermore, in alcohol-preferring rats that received RYGB, the reduction in alcohol consumption was associated with elevated GLP-1 concentrations in the blood plasma. For rats undergoing sham surgery, the use of a GLP1-R agonist initiated an equivalent reduction in alcohol consumption. In addition, ghrelin replacement was followed by restoration of the drinking behavior in rats that preferred alcohol, but it did not have any effect on rats that were sham-operated [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>].Overall, these results validate that GLP-1 and ghrelin may contribute to the initial decrease in alcohol consumption noted following RYGB. However, further studies are necessary to explore the roles of ghrelin, GLP-1, and other gut endocrine hormones. The function of gastrointestinal hormones in addiction to other substances, such as opioids, post-bariatric surgery is yet to be ascertained.</p></sec></sec><sec id="Sec7"><title>Limitations</title><p id="Par27">It is important to acknowledge several limitations to this study. First, heterogeneity in the quality-of-life assessment instruments employed by the included studies introduces potential bias into the findings. Second, the extensive scope of this review has precluded a sufficiently comprehensive and in-depth synthesis of all involved domains. Furthermore, the majority of clinical evidence is derived from short-to-medium-term follow-up (&#8804;&#8201;5&#160;years), precluding the formulation of definitive conclusions regarding the long-term adaptive responses of the gut&#8211;brain axis. Finally, in certain sections of this review, studies utilizing rodent models constitute a relatively high proportion, whereas human clinical data remain limited. In addition, the translational validity of these animal models to human outcomes has not been fully established, which may contribute to overstatement of the reported results.</p></sec><sec id="Sec8"><title>Discussion</title><p id="Par28">Bariatric surgery is an established obesity management intervention that significantly improves metabolic profiles, achieves effective and sustained weight loss, and maintains long-term weight stability. This procedure operates through multiple mechanisms: beyond its weight-reducing effects, it is closely linked to changes in patients&#8217; quality of life and psychological well-being. To date, the majority of studies have demonstrated that bariatric surgery enhances post-operative quality of life and psychological status; however, a small subset of patients experience diminished quality of life and adverse psychological changes following surgery. This review provides an in-depth analysis of the potential mechanism underlying this phenomenon&#8212;the gut&#8211;brain axis. Despite some inconsistent findings, accumulating evidence indicates that alterations in gut&#8211;brain axis signaling pathways post-bariatric surgery are associated with mental health and quality-of-life outcomes.</p><p id="Par29">To date, neither the association between the gut&#8211;brain axis and post-surgical changes in mental health and quality of life nor the translational validity of animal model findings to clinical trials has been scientifically established. Therefore, in addition to further elucidating the complex interplay within the gut&#8211;brain axis, future research should prioritize the following study designs to advance the field: validating rodent-derived mechanisms in large-scale human randomized controlled trials (with IRB approval), such as probiotic supplementation for gut dysbiosis (e.g., <italic toggle="yes">Bifidobacterium</italic> strains) [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR20">20</xref>] and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for addictive behavior transfer intervention [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>];Developing a quality-of-life database specific to Chinese patients using validated cross-cultural adaptation protocols, with scores from diverse assessment tools converted to standardized mean differences (SMDs) to strengthen result comparability and reliability; Implementing long-term standardized monitoring and assessment (&#8805;&#8201;10&#160;years) of post-bariatric surgery patients&#8217; quality of life, gut hormone levels, and gut microbiota profiles to generate robust longitudinal data. Such research has the potential to deliver more comprehensive and durable health benefits to patients.</p></sec><sec id="Sec9"><title>Conclusion</title><p id="Par30">Through an in-depth exploration of these mechanisms, researchers hope to reveal the specific associations between bariatric surgery and life quality, thereby further optimizing surgical plans to provide personalized treatment services for patients. At the same time, this will help clinical doctors to more accurately identify potential psychological risks in the preoperative assessment process, and formulating corresponding preventive measures.</p><p id="Par31">In future research, with the aid of advanced scientific and technological methods, it will be possible to more comprehensively analyze the mechanisms of the gut&#8211;brain axis, offering innovative therapeutic approaches to improve patients&#8217; postoperative quality of life. This will not only promote the personalized development of surgical plans but also provide a scientific basis for psychological health interventions, which will help in formulating targeted preoperative consultations and postoperative support plans, ensuring that patients achieve comprehensive physical and mental health improvements during the weight loss process.</p><p id="Par32">On this basis, interdisciplinary cooperation will be crucial. By integrating research findings from various fields, such as endocrinology, psychology, and nutrition, a more comprehensive treatment system can be established for patients, thereby better meeting their needs and improving treatment outcomes.</p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>As the first author, YXJ was responsible for determining the topic and scope of the manuscript, systematically searching for and screening relevant literature, writing the main body of the review, and integrating the contributions of the other authors.In addition, YXJ also revised the manuscript multiple times to ensure the accuracy and coherence of the content and worked closely with the corresponding author to complete the final submission of the manuscript. SHZ and HCX provided expert advice on the selection of the topic and the research direction of the manuscript. SHZ and HCX also offered key academic insights during the process of literature screening and analysis and conducted a detailed review and revision of the initial draft. DH conducted an initial evaluation of the overall structure and content of the manuscript and reviewed and revised the manuscript. YHW and YFW assisted with the collection and organization of the literature materials. All authors have reviewed the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>No funding.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analyzed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par33">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pan</surname><given-names>XF</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Pan</surname><given-names>A</given-names></name></person-group><article-title>Epidemiology and determinants of obesity in China</article-title><source>Lancet Diabetes Endocrinol</source><year>2021</year><volume>9</volume><issue>6</issue><fpage>373</fpage><lpage>392</lpage><pub-id pub-id-type="pmid">34022156</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2213-8587(21)00045-0</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Pan XF, Wang L, Pan A (2021) Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol 9(6):373&#8211;392<pub-id pub-id-type="pmid">34022156</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2213-8587(21)00045-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">Clinical Nutrition Branch of Chinese Nutrition Society, Chinese Diabetes Society, et al (2022) Guidelines for medicalnutrition treatment of overweight/obesity in China (2021). Asia Pac J Clin Nutr 31(3):450&#8211;482.</mixed-citation></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name><name name-style="western"><surname>Gao</surname><given-names>L</given-names></name><name name-style="western"><surname>Pan</surname><given-names>A</given-names></name><name name-style="western"><surname>Xue</surname><given-names>H</given-names></name></person-group><article-title>Health policy and public health implications of obesity in China</article-title><source>Lancet Diabetes Endocrinol</source><year>2021</year><volume>9</volume><issue>7</issue><fpage>46</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">34097869</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2213-8587(21)00118-2</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Wang Y, Zhao L, Gao L, Pan A, Xue H (2021) Health policy and public health implications of obesity in China. Lancet Diabetes Endocrinol 9(7):46&#8211;61<pub-id pub-id-type="pmid">34097869</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2213-8587(21)00118-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Busebee</surname><given-names>B</given-names></name><name name-style="western"><surname>Ghusn</surname><given-names>W</given-names></name><name name-style="western"><surname>Cifuentes</surname><given-names>L</given-names></name><etal/></person-group><article-title>Obesity: a review of pathophysiology and classification</article-title><source>Mayo Clin Proc</source><year>2023</year><volume>98</volume><issue>12</issue><fpage>1842</fpage><lpage>1857</lpage><pub-id pub-id-type="pmid">37831039</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mayocp.2023.05.026</pub-id><pub-id pub-id-type="pmcid">PMC10843116</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Busebee B, Ghusn W, Cifuentes L et al (2023) Obesity: a review of pathophysiology and classification. Mayo Clin Proc 98(12):1842&#8211;1857<pub-id pub-id-type="pmid">37831039</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mayocp.2023.05.026</pub-id><pub-id pub-id-type="pmcid">PMC10843116</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mingrone</surname><given-names>G</given-names></name><name name-style="western"><surname>Panunzi</surname><given-names>S</given-names></name><name name-style="western"><surname>De Gaetano</surname><given-names>A</given-names></name><etal/></person-group><article-title>Bariatric surgery versus conventional medical therapy for type 2 diabetes</article-title><source>N Engl J Med</source><year>2012</year><volume>366</volume><issue>17</issue><fpage>1577</fpage><lpage>1585</lpage><pub-id pub-id-type="pmid">22449317</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa1200111</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Mingrone G, Panunzi S, De Gaetano A et al (2012) Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366(17):1577&#8211;1585<pub-id pub-id-type="pmid">22449317</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa1200111</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>CR</given-names></name><name name-style="western"><surname>Osadchiy</surname><given-names>V</given-names></name><name name-style="western"><surname>Kalani</surname><given-names>A</given-names></name><name name-style="western"><surname>Mayer</surname><given-names>EA</given-names></name></person-group><article-title>The brain-gut-microbiome axis</article-title><source>Cell Mol Gastroenterol Hepatol</source><year>2018</year><volume>6</volume><issue>2</issue><fpage>133</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">30023410</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcmgh.2018.04.003</pub-id><pub-id pub-id-type="pmcid">PMC6047317</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Martin CR, Osadchiy V, Kalani A, Mayer EA (2018) The brain-gut-microbiome axis. Cell Mol Gastroenterol Hepatol 6(2):133&#8211;148<pub-id pub-id-type="pmid">30023410</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcmgh.2018.04.003</pub-id><pub-id pub-id-type="pmcid">PMC6047317</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Castaneda</surname><given-names>D</given-names></name><etal/></person-group><article-title>Risk of suicide and self-harm is increased after bariatric surgery-a systematic review and meta-analysis</article-title><source>Obes Surg</source><year>2019</year><volume>29</volume><issue>1</issue><fpage>322</fpage><lpage>333</lpage><pub-id pub-id-type="pmid">30343409</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11695-018-3493-4</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Castaneda D et al (2019) Risk of suicide and self-harm is increased after bariatric surgery-a systematic review and meta-analysis. Obes Surg 29(1):322&#8211;333<pub-id pub-id-type="pmid">30343409</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11695-018-3493-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Bariatric and Diabetic Surgeons Committee, Surgeons Branch, Chinese Medical Association (2018) Guidelines for laparoscopic sleeve gastrectomy. Chin Electr J Obes Metab Dis 4(4):196&#8211;201.</mixed-citation></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Climaco</surname><given-names>K</given-names></name><name name-style="western"><surname>Ahnfeldt</surname><given-names>E</given-names></name></person-group><article-title>Laparoscopic vertical sleeve gastrectomy</article-title><source>Surg Clin North Am</source><year>2021</year><volume>101</volume><issue>2</issue><fpage>177</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">33743962</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.suc.2020.12.015</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Climaco K, Ahnfeldt E (2021) Laparoscopic vertical sleeve gastrectomy. Surg Clin North Am 101(2):177&#8211;188<pub-id pub-id-type="pmid">33743962</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.suc.2020.12.015</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Custers</surname><given-names>E</given-names></name><etal/></person-group><article-title>Bariatric surgery and gut-brain-axis driven alterations in cognition and inflammation</article-title><source>J Inflamm Res</source><year>2023</year><volume>16</volume><fpage>5495</fpage><lpage>5514</lpage><pub-id pub-id-type="pmid">38026245</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/JIR.S437156</pub-id><pub-id pub-id-type="pmcid">PMC10676679</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Custers E et al (2023) Bariatric surgery and gut-brain-axis driven alterations in cognition and inflammation. J Inflamm Res 16:5495&#8211;5514<pub-id pub-id-type="pmid">38026245</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/JIR.S437156</pub-id><pub-id pub-id-type="pmcid">PMC10676679</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qin</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>R</given-names></name><name name-style="western"><surname>Raes</surname><given-names>J</given-names></name><etal/></person-group><article-title>A human gut microbial gene catalogue established by metagenomic sequencing</article-title><source>Nature</source><year>2010</year><volume>464</volume><issue>7285</issue><fpage>59</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">20203603</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature08821</pub-id><pub-id pub-id-type="pmcid">PMC3779803</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Qin J, Li R, Raes J et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285):59&#8211;65<pub-id pub-id-type="pmid">20203603</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature08821</pub-id><pub-id pub-id-type="pmcid">PMC3779803</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ley</surname><given-names>RE</given-names></name><name name-style="western"><surname>B&#228;ckhed</surname><given-names>F</given-names></name><name name-style="western"><surname>Turnbaugh</surname><given-names>P</given-names></name><etal/></person-group><article-title>Obesity alters gut microbial ecology</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><issue>31</issue><fpage>11070</fpage><lpage>11075</lpage><pub-id pub-id-type="pmid">16033867</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0504978102</pub-id><pub-id pub-id-type="pmcid">PMC1176910</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Ley RE, B&#228;ckhed F, Turnbaugh P et al (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102(31):11070&#8211;11075<pub-id pub-id-type="pmid">16033867</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0504978102</pub-id><pub-id pub-id-type="pmcid">PMC1176910</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Le Chatelier</surname><given-names>E</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>T</given-names></name><name name-style="western"><surname>Qin</surname><given-names>J</given-names></name><etal/></person-group><article-title>Richness of human gut microbiome correlates with metabolic markers</article-title><source>Nature</source><year>2013</year><volume>500</volume><issue>7464</issue><fpage>541</fpage><lpage>546</lpage><pub-id pub-id-type="pmid">23985870</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature12506</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Le Chatelier E, Nielsen T, Qin J et al (2013) Richness of human gut microbiome correlates with metabolic markers. Nature 500(7464):541&#8211;546<pub-id pub-id-type="pmid">23985870</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature12506</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naseribafrouei</surname><given-names>A</given-names></name><name name-style="western"><surname>Hestad</surname><given-names>K</given-names></name><name name-style="western"><surname>Avershina</surname><given-names>E</given-names></name><etal/></person-group><article-title>Correlation between the human fecal microbiota and depression</article-title><source>Neurogastroenterol Motil</source><year>2014</year><volume>26</volume><issue>8</issue><fpage>1155</fpage><lpage>1162</lpage><pub-id pub-id-type="pmid">24888394</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/nmo.12378</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Naseribafrouei A, Hestad K, Avershina E et al (2014) Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil 26(8):1155&#8211;1162<pub-id pub-id-type="pmid">24888394</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/nmo.12378</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>HY</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Yu</surname><given-names>ZH</given-names></name><etal/></person-group><article-title>Altered gut microbiota profile in patients with generalized anxiety disorder</article-title><source>J Psychiatr Res</source><year>2018</year><volume>104</volume><fpage>130</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">30029052</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpsychires.2018.07.007</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Jiang HY, Zhang X, Yu ZH et al (2018) Altered gut microbiota profile in patients with generalized anxiety disorder. J Psychiatr Res 104:130&#8211;136<pub-id pub-id-type="pmid">30029052</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpsychires.2018.07.007</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diaz Heijtz</surname><given-names>R</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Anuar</surname><given-names>F</given-names></name><etal/></person-group><article-title>Normal gut microbiota modulates brain development and behavior</article-title><source>Proc Natl Acad Sci USA</source><year>2011</year><volume>108</volume><issue>7</issue><fpage>3047</fpage><lpage>3052</lpage><pub-id pub-id-type="pmid">21282636</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1010529108</pub-id><pub-id pub-id-type="pmcid">PMC3041077</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Diaz Heijtz R, Wang S, Anuar F et al (2011) Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 108(7):3047&#8211;3052 (<bold>J</bold>)<pub-id pub-id-type="pmid">21282636</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1010529108</pub-id><pub-id pub-id-type="pmcid">PMC3041077</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>P</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>C</given-names></name><etal/></person-group><article-title>Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism</article-title><source>Mol Psychiatry</source><year>2016</year><volume>21</volume><issue>6</issue><fpage>786</fpage><lpage>796</lpage><pub-id pub-id-type="pmid">27067014</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/mp.2016.44</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Zheng P, Zeng B, Zhou C et al (2016) Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host&#8217;s metabolism. Mol Psychiatry 21(6):786&#8211;796<pub-id pub-id-type="pmid">27067014</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/mp.2016.44</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelly</surname><given-names>JR</given-names></name><name name-style="western"><surname>Borre</surname><given-names>Y</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>C</given-names></name><etal/></person-group><article-title>Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat</article-title><source>J Psychiatr Res</source><year>2016</year><volume>82</volume><fpage>109</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">27491067</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpsychires.2016.07.019</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Kelly JR, Borre Y, O&#8217;Brien C et al (2016) Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res 82:109&#8211;118<pub-id pub-id-type="pmid">27491067</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpsychires.2016.07.019</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>L</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hashimoto</surname><given-names>K</given-names></name></person-group><article-title>Brain-gut-microbiota axis in depression: a historical overview and future directions</article-title><source>Brain Res Bull</source><year>2022</year><volume>182</volume><fpage>44</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">35151796</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.brainresbull.2022.02.004</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Chang L, Wei Y, Hashimoto K (2022) Brain-gut-microbiota axis in depression: a historical overview and future directions. Brain Res Bull 182:44&#8211;56<pub-id pub-id-type="pmid">35151796</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.brainresbull.2022.02.004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Navarro-Tapia</surname><given-names>E</given-names></name><name name-style="western"><surname>Almeida-Toledano</surname><given-names>L</given-names></name><name name-style="western"><surname>Sebastiani</surname><given-names>G</given-names></name><name name-style="western"><surname>Serra-Delgado</surname><given-names>M</given-names></name><name name-style="western"><surname>Garc&#237;a-Algar</surname><given-names>&#211;</given-names></name><name name-style="western"><surname>Andreu-Fern&#225;ndez</surname><given-names>V</given-names></name></person-group><article-title>Effects of microbiota imbalance in anxiety and eating disorders: probiotics as novel therapeutic approaches</article-title><source>Int J Mol Sci</source><year>2021</year><volume>22</volume><issue>5</issue><fpage>2351</fpage><pub-id pub-id-type="pmid">33652962</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms22052351</pub-id><pub-id pub-id-type="pmcid">PMC7956573</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Navarro-Tapia E, Almeida-Toledano L, Sebastiani G, Serra-Delgado M, Garc&#237;a-Algar &#211;, Andreu-Fern&#225;ndez V (2021) Effects of microbiota imbalance in anxiety and eating disorders: probiotics as novel therapeutic approaches. Int J Mol Sci 22(5):2351<pub-id pub-id-type="pmid">33652962</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms22052351</pub-id><pub-id pub-id-type="pmcid">PMC7956573</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beumer</surname><given-names>J</given-names></name><name name-style="western"><surname>Geurts</surname><given-names>MH</given-names></name><name name-style="western"><surname>Geurts</surname><given-names>V</given-names></name><etal/></person-group><article-title>Description and functional validation of human enteroendocrine cell sensors</article-title><source>Science</source><year>2024</year><volume>386</volume><issue>6719</issue><fpage>341</fpage><lpage>348</lpage><pub-id pub-id-type="pmid">39418382</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.adl1460</pub-id><pub-id pub-id-type="pmcid">PMC7616728</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Beumer J, Geurts MH, Geurts V et al (2024) Description and functional validation of human enteroendocrine cell sensors. Science 386(6719):341&#8211;348<pub-id pub-id-type="pmid">39418382</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.adl1460</pub-id><pub-id pub-id-type="pmcid">PMC7616728</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hayashi</surname><given-names>M</given-names></name><name name-style="western"><surname>Kaye</surname><given-names>JA</given-names></name><name name-style="western"><surname>Douglas</surname><given-names>ER</given-names></name><etal/></person-group><article-title>Enteroendocrine cell lineages that differentially control feeding and gut motility</article-title><source>Elife</source><year>2023</year><volume>12</volume><fpage>e78512</fpage><pub-id pub-id-type="pmid">36810133</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7554/eLife.78512</pub-id><pub-id pub-id-type="pmcid">PMC10032656</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Hayashi M, Kaye JA, Douglas ER et al (2023) Enteroendocrine cell lineages that differentially control feeding and gut motility. Elife 12:e78512 (<bold>J</bold>)<pub-id pub-id-type="pmid">36810133</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7554/eLife.78512</pub-id><pub-id pub-id-type="pmcid">PMC10032656</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Isacson</surname><given-names>R</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>E</given-names></name><name name-style="western"><surname>Dannaeus</surname><given-names>K</given-names></name><etal/></person-group><article-title>The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test</article-title><source>Eur J Pharmacol</source><year>2011</year><volume>650</volume><issue>1</issue><fpage>249</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">20951130</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejphar.2010.10.008</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Isacson R, Nielsen E, Dannaeus K et al (2011) The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test. Eur J Pharmacol 650(1):249&#8211;255<pub-id pub-id-type="pmid">20951130</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejphar.2010.10.008</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderberg</surname><given-names>RH</given-names></name><name name-style="western"><surname>Richard</surname><given-names>JE</given-names></name><name name-style="western"><surname>Hansson</surname><given-names>C</given-names></name><etal/></person-group><article-title>GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality</article-title><source>Psychoneuroendocrinology</source><year>2016</year><volume>65</volume><fpage>54</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">26724568</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.psyneuen.2015.11.021</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Anderberg RH, Richard JE, Hansson C et al (2016) GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality. Psychoneuroendocrinology 65:54&#8211;66<pub-id pub-id-type="pmid">26724568</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.psyneuen.2015.11.021</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strawn</surname><given-names>JR</given-names></name><name name-style="western"><surname>D'Alessio</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Failure of glucagon-like peptide-1 to induce panic attacks or anxiety in patients with panic disorder</article-title><source>J Psychiatr Res</source><year>2008</year><volume>42</volume><issue>9</issue><fpage>787</fpage><lpage>789</lpage><pub-id pub-id-type="pmid">17888452</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpsychires.2007.08.007</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Strawn JR, D&#8217;Alessio DA et al (2008) Failure of glucagon-like peptide-1 to induce panic attacks or anxiety in patients with panic disorder. J Psychiatr Res 42(9):787&#8211;789<pub-id pub-id-type="pmid">17888452</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpsychires.2007.08.007</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Bloemendaal</surname><given-names>L</given-names></name><name name-style="western"><surname>IJzerman</surname><given-names>RG</given-names></name><name name-style="western"><surname>Ten Kulve</surname><given-names>JS</given-names></name><etal/></person-group><article-title>GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans</article-title><source>Diabetes</source><year>2014</year><volume>63</volume><issue>12</issue><fpage>4186</fpage><lpage>4196</lpage><pub-id pub-id-type="pmid">25071023</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/db14-0849</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">van Bloemendaal L, IJzerman RG, Ten Kulve JS et al (2014) GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans. Diabetes 63(12):4186&#8211;4196<pub-id pub-id-type="pmid">25071023</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/db14-0849</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alvarez-Crespo</surname><given-names>M</given-names></name><name name-style="western"><surname>Skibicka</surname><given-names>KP</given-names></name><name name-style="western"><surname>Farkas</surname><given-names>I</given-names></name><etal/></person-group><article-title>The amygdala as a neurobiological target for ghrelin in rats: neuroanatomical, electrophysiological and behavioral evidence</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><issue>10</issue><fpage>e46321</fpage><pub-id pub-id-type="pmid">23071554</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0046321</pub-id><pub-id pub-id-type="pmcid">PMC3468604</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Alvarez-Crespo M, Skibicka KP, Farkas I et al (2012) The amygdala as a neurobiological target for ghrelin in rats: neuroanatomical, electrophysiological and behavioral evidence. PLoS ONE 7(10):e46321<pub-id pub-id-type="pmid">23071554</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0046321</pub-id><pub-id pub-id-type="pmcid">PMC3468604</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spencer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Xu</surname><given-names>L</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress</article-title><source>Biol Psychiatry</source><year>2012</year><volume>72</volume><issue>6</issue><fpage>457</fpage><lpage>465</lpage><pub-id pub-id-type="pmid">22521145</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopsych.2012.03.010</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Spencer SJ, Xu L, Clarke MA et al (2012) Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress. Biol Psychiatry 72(6):457&#8211;465<pub-id pub-id-type="pmid">22521145</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopsych.2012.03.010</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Niu</surname><given-names>M</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Acute but not chronic calorie restriction defends against stress-related anxiety and despair in a GHS-R1a-dependent manner</article-title><source>Neuroscience</source><year>2019</year><volume>412</volume><fpage>94</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">31185255</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuroscience.2019.05.067</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Lu Y, Niu M, Qiu X et al (2019) Acute but not chronic calorie restriction defends against stress-related anxiety and despair in a GHS-R1a-dependent manner. Neuroscience 412:94&#8211;104<pub-id pub-id-type="pmid">31185255</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuroscience.2019.05.067</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carlini</surname><given-names>VP</given-names></name><name name-style="western"><surname>Machado</surname><given-names>DG</given-names></name><name name-style="western"><surname>Buteler</surname><given-names>F</given-names></name><etal/></person-group><article-title>Acute ghrelin administration reverses depressive-like behavior induced by bilateral olfactory bulbectomy in mice</article-title><source>Peptides</source><year>2012</year><volume>35</volume><issue>2</issue><fpage>160</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">22525660</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.peptides.2012.03.031</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Carlini VP, Machado DG, Buteler F et al (2012) Acute ghrelin administration reverses depressive-like behavior induced by bilateral olfactory bulbectomy in mice. Peptides 35(2):160&#8211;165<pub-id pub-id-type="pmid">22525660</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.peptides.2012.03.031</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>L</given-names></name><name name-style="western"><surname>Niu</surname><given-names>F</given-names></name><name name-style="western"><surname>Li</surname><given-names>B</given-names></name></person-group><article-title>Ghrelin/GHSR signaling in the lateral septum ameliorates chronic stress-induced depressive-like behaviors</article-title><source>Prog Neuropsychopharmacol Biol Psychiatry</source><year>2024</year><volume>131</volume><fpage>110953</fpage><pub-id pub-id-type="pmid">38278286</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pnpbp.2024.110953</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Chang L, Niu F, Li B (2024) Ghrelin/GHSR signaling in the lateral septum ameliorates chronic stress-induced depressive-like behaviors. Prog Neuropsychopharmacol Biol Psychiatry 131:110953<pub-id pub-id-type="pmid">38278286</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pnpbp.2024.110953</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adrian</surname><given-names>TE</given-names></name><name name-style="western"><surname>Allen</surname><given-names>JM</given-names></name><name name-style="western"><surname>Bloom</surname><given-names>SR</given-names></name><etal/></person-group><article-title>Neuropeptide Y distribution in human brain</article-title><source>Nature</source><year>1983</year><volume>306</volume><issue>5943</issue><fpage>584</fpage><lpage>586</lpage><pub-id pub-id-type="pmid">6358901</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/306584a0</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Adrian TE, Allen JM, Bloom SR et al (1983) Neuropeptide Y distribution in human brain. Nature 306(5943):584&#8211;586<pub-id pub-id-type="pmid">6358901</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/306584a0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shende</surname><given-names>P</given-names></name><name name-style="western"><surname>Desai</surname><given-names>D</given-names></name></person-group><article-title>Physiological and therapeutic roles of neuropeptide Y on biological functions</article-title><source>Adv Exp Med Biol</source><year>2020</year><volume>1237</volume><fpage>37</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">31468359</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/5584_2019_427</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Shende P, Desai D (2020) Physiological and therapeutic roles of neuropeptide Y on biological functions. Adv Exp Med Biol 1237:37&#8211;47<pub-id pub-id-type="pmid">31468359</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/5584_2019_427</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>G</given-names></name><name name-style="western"><surname>Hariri</surname><given-names>AR</given-names></name><etal/></person-group><article-title>Genetic variation in human NPY expression affects stress response and emotion</article-title><source>Nature</source><year>2008</year><volume>452</volume><issue>7190</issue><fpage>997</fpage><lpage>1001</lpage><pub-id pub-id-type="pmid">18385673</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature06858</pub-id><pub-id pub-id-type="pmcid">PMC2715959</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Zhou Z, Zhu G, Hariri AR et al (2008) Genetic variation in human NPY expression affects stress response and emotion. Nature 452(7190):997&#8211;1001 (<bold>J</bold>)<pub-id pub-id-type="pmid">18385673</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature06858</pub-id><pub-id pub-id-type="pmcid">PMC2715959</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Hu</surname><given-names>W</given-names></name><etal/></person-group><article-title>Identification of functional farnesoid X receptors in brain neurons</article-title><source>FEBS Lett</source><year>2016</year><volume>590</volume><issue>18</issue><fpage>3233</fpage><lpage>3242</lpage><pub-id pub-id-type="pmid">27545319</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1873-3468.12373</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Huang C, Wang J, Hu W et al (2016) Identification of functional farnesoid X receptors in brain neurons. FEBS Lett 590(18):3233&#8211;3242 (<bold>J</bold>)<pub-id pub-id-type="pmid">27545319</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1873-3468.12373</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>WG</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>JX</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Hippocampal FXR plays a role in the pathogenesis of depression: a preliminary study based on lentiviral gene modulation</article-title><source>Psychiatry Res</source><year>2018</year><volume>264</volume><fpage>374</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">29677620</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.psychres.2018.04.025</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Chen WG, Zheng JX, Xu X et al (2018) Hippocampal FXR plays a role in the pathogenesis of depression: a preliminary study based on lentiviral gene modulation. Psychiatry Res 264:374&#8211;379 (<bold>J</bold>)<pub-id pub-id-type="pmid">29677620</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.psychres.2018.04.025</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>F</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T</given-names></name><name name-style="western"><surname>Lan</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Deletion of mouse FXR gene disturbs multiple neurotransmitter systems and alters neurobehavior</article-title><source>Front Behav Neurosci</source><year>2015</year><volume>9</volume><fpage>70</fpage><pub-id pub-id-type="pmid">25870546</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnbeh.2015.00070</pub-id><pub-id pub-id-type="pmcid">PMC4378301</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Huang F, Wang T, Lan Y et al (2015) Deletion of mouse FXR gene disturbs multiple neurotransmitter systems and alters neurobehavior. Front Behav Neurosci 9:70 (<bold>J</bold>)<pub-id pub-id-type="pmid">25870546</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnbeh.2015.00070</pub-id><pub-id pub-id-type="pmcid">PMC4378301</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cain</surname><given-names>BM</given-names></name><name name-style="western"><surname>Connolly</surname><given-names>K</given-names></name><name name-style="western"><surname>Blum</surname><given-names>A</given-names></name><etal/></person-group><article-title>Distribution and colocalization of cholecystokinin with the prohormone convertase enzymes PC1, PC2, and PC5 in rat brain</article-title><source>J Comp Neurol</source><year>2003</year><volume>467</volume><issue>3</issue><fpage>307</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">14608596</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cne.10924</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Cain BM, Connolly K, Blum A et al (2003) Distribution and colocalization of cholecystokinin with the prohormone convertase enzymes PC1, PC2, and PC5 in rat brain. J Comp Neurol 467(3):307&#8211;325<pub-id pub-id-type="pmid">14608596</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cne.10924</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rehfeld</surname><given-names>JF</given-names></name></person-group><article-title>Cholecystokinin and panic disorder: reflections on the history and some unsolved questions</article-title><source>Molecules</source><year>2021</year><volume>26</volume><issue>18</issue><fpage>5657</fpage><pub-id pub-id-type="pmid">34577128</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/molecules26185657</pub-id><pub-id pub-id-type="pmcid">PMC8469898</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Rehfeld JF (2021) Cholecystokinin and panic disorder: reflections on the history and some unsolved questions. Molecules 26(18):5657 (<bold>J</bold>)<pub-id pub-id-type="pmid">34577128</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/molecules26185657</pub-id><pub-id pub-id-type="pmcid">PMC8469898</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geraci</surname><given-names>M</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>TS</given-names></name><name name-style="western"><surname>Slate-Cothren</surname><given-names>S</given-names></name><etal/></person-group><article-title>Pentagastrin-induced sleep panic attacks: panic in the absence of elevated baseline arousal</article-title><source>Biol Psychiatry</source><year>2002</year><volume>52</volume><issue>12</issue><fpage>1183</fpage><lpage>1189</lpage><pub-id pub-id-type="pmid">12488064</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0006-3223(02)01402-6</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Geraci M, Anderson TS, Slate-Cothren S et al (2002) Pentagastrin-induced sleep panic attacks: panic in the absence of elevated baseline arousal. Biol Psychiatry 52(12):1183&#8211;1189 (<bold>J</bold>)<pub-id pub-id-type="pmid">12488064</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0006-3223(02)01402-6</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bradwejn</surname><given-names>J</given-names></name><name name-style="western"><surname>Koszycki</surname><given-names>D</given-names></name><name name-style="western"><surname>Cou&#235;toux du Tertre</surname><given-names>A</given-names></name><etal/></person-group><article-title>The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder</article-title><source>Arch Gen Psychiatry</source><year>1994</year><volume>51</volume><issue>6</issue><fpage>486</fpage><lpage>493</lpage><pub-id pub-id-type="pmid">8192551</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archpsyc.1994.03950060050005</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Bradwejn J, Koszycki D, Cou&#235;toux du Tertre A et al (1994) The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder. Arch Gen Psychiatry 51(6):486&#8211;493<pub-id pub-id-type="pmid">8192551</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archpsyc.1994.03950060050005</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adams</surname><given-names>JB</given-names></name><name name-style="western"><surname>Pyke</surname><given-names>RE</given-names></name><name name-style="western"><surname>Costa</surname><given-names>J</given-names></name><etal/></person-group><article-title>A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder</article-title><source>J Clin Psychopharmacol</source><year>1995</year><volume>15</volume><issue>6</issue><fpage>428</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">8748432</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00004714-199512000-00007</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Adams JB, Pyke RE, Costa J et al (1995) A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder. J Clin Psychopharmacol 15(6):428&#8211;434 (<bold>J</bold>)<pub-id pub-id-type="pmid">8748432</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00004714-199512000-00007</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kramer</surname><given-names>MS</given-names></name><name name-style="western"><surname>Cutler</surname><given-names>NR</given-names></name><name name-style="western"><surname>Ballenger</surname><given-names>JC</given-names></name><etal/></person-group><article-title>A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder</article-title><source>Biol Psychiatry</source><year>1995</year><volume>37</volume><issue>7</issue><fpage>462</fpage><lpage>466</lpage><pub-id pub-id-type="pmid">7786960</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0006-3223(94)00190-E</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Kramer MS, Cutler NR, Ballenger JC et al (1995) A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder. Biol Psychiatry 37(7):462&#8211;466<pub-id pub-id-type="pmid">7786960</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0006-3223(94)00190-E</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kellner</surname><given-names>M</given-names></name></person-group><article-title>Experimental panic provocation in healthy man-a translational role in anti-panic drug development?</article-title><source>Dialogues Clin Neurosci</source><year>2011</year><volume>13</volume><issue>4</issue><fpage>485</fpage><lpage>493</lpage><pub-id pub-id-type="pmid">22275853</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.31887/DCNS.2011.13.4/mkellner</pub-id><pub-id pub-id-type="pmcid">PMC3263395</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Kellner M (2011) Experimental panic provocation in healthy man-a translational role in anti-panic drug development? Dialogues Clin Neurosci 13(4):485&#8211;493 (<bold>J</bold>)<pub-id pub-id-type="pmid">22275853</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.31887/DCNS.2011.13.4/mkellner</pub-id><pub-id pub-id-type="pmcid">PMC3263395</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nestor</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Ersche</surname><given-names>KD</given-names></name></person-group><article-title>Gut hormones: possible mediators of addictive disorders?</article-title><source>Eur Addict Res</source><year>2024</year><volume>10</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000540743</pub-id><pub-id pub-id-type="pmid">39389039</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Nestor LJ, Ersche KD (2024) Gut hormones: possible mediators of addictive disorders? Eur Addict Res 10:1&#8211;8<pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000540743</pub-id><pub-id pub-id-type="pmid">39389039</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>&#350;en</surname><given-names>O</given-names></name><name name-style="western"><surname>&#220;n&#252;bol</surname><given-names>H</given-names></name><name name-style="western"><surname>G&#246;khan T&#252;rk&#231;apar</surname><given-names>A</given-names></name><etal/></person-group><article-title>Risk of alcohol use disorder after sleeve gastrectomy</article-title><source>J Laparoendosc Adv Surg Tech A</source><year>2021</year><volume>31</volume><issue>1</issue><fpage>24</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">32525729</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/lap.2020.0306</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">&#350;en O, &#220;n&#252;bol H, G&#246;khan T&#252;rk&#231;apar A et al (2021) Risk of alcohol use disorder after sleeve gastrectomy. J Laparoendosc Adv Surg Tech A 31(1):24&#8211;28 (<bold>J</bold>)<pub-id pub-id-type="pmid">32525729</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/lap.2020.0306</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Wu</surname><given-names>LT</given-names></name></person-group><article-title>Substance use after bariatric surgery: a review</article-title><source>J Psychiatr Res</source><year>2016</year><volume>76</volume><fpage>16</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">26871733</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpsychires.2016.01.009</pub-id><pub-id pub-id-type="pmcid">PMC4789154</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Li L, Wu LT (2016) Substance use after bariatric surgery: a review. J Psychiatr Res 76:16&#8211;29<pub-id pub-id-type="pmid">26871733</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpsychires.2016.01.009</pub-id><pub-id pub-id-type="pmcid">PMC4789154</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simoni</surname><given-names>AH</given-names></name><name name-style="western"><surname>Ladebo</surname><given-names>L</given-names></name><name name-style="western"><surname>Christrup</surname><given-names>LL</given-names></name><etal/></person-group><article-title>Chronic abdominal pain and persistent opioid use after bariatric surgery</article-title><source>Scand J Pain</source><year>2020</year><volume>20</volume><issue>2</issue><fpage>239</fpage><lpage>251</lpage><pub-id pub-id-type="pmid">31756166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1515/sjpain-2019-0092</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Simoni AH, Ladebo L, Christrup LL et al (2020) Chronic abdominal pain and persistent opioid use after bariatric surgery. Scand J Pain 20(2):239&#8211;251 (<bold>J</bold>)<pub-id pub-id-type="pmid">31756166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1515/sjpain-2019-0092</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raebel</surname><given-names>MA</given-names></name><name name-style="western"><surname>Newcomer</surname><given-names>SR</given-names></name><name name-style="western"><surname>Reifler</surname><given-names>LM</given-names></name><etal/></person-group><article-title>Chronic use of opioid medications before and after bariatric surgery</article-title><source>JAMA</source><year>2013</year><volume>310</volume><issue>13</issue><fpage>1369</fpage><lpage>1376</lpage><pub-id pub-id-type="pmid">24084922</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2013.278344</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Raebel MA, Newcomer SR, Reifler LM et al (2013) Chronic use of opioid medications before and after bariatric surgery. JAMA 310(13):1369&#8211;1376 (<bold>J</bold>)<pub-id pub-id-type="pmid">24084922</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2013.278344</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koball</surname><given-names>AM</given-names></name><name name-style="western"><surname>Ames</surname><given-names>G</given-names></name><name name-style="western"><surname>Goetze</surname><given-names>RE</given-names></name></person-group><article-title>Addiction transfer and other behavioral changes following bariatric surgery</article-title><source>Surg Clin North Am</source><year>2021</year><volume>101</volume><issue>2</issue><fpage>323</fpage><lpage>333</lpage><pub-id pub-id-type="pmid">33743972</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.suc.2020.12.005</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Koball AM, Ames G, Goetze RE (2021) Addiction transfer and other behavioral changes following bariatric surgery. Surg Clin North Am 101(2):323&#8211;333<pub-id pub-id-type="pmid">33743972</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.suc.2020.12.005</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>King</surname><given-names>WC</given-names></name><name name-style="western"><surname>Chen</surname><given-names>JY</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Prevalence of alcohol use disorders before and after bariatric surgery</article-title><source>JAMA</source><year>2012</year><volume>307</volume><issue>23</issue><fpage>2516</fpage><lpage>2525</lpage><pub-id pub-id-type="pmid">22710289</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2012.6147</pub-id><pub-id pub-id-type="pmcid">PMC3682834</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">King WC, Chen JY, Mitchell JE et al (2012) Prevalence of alcohol use disorders before and after bariatric surgery. JAMA 307(23):2516&#8211;2525 (<bold>J</bold>)<pub-id pub-id-type="pmid">22710289</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2012.6147</pub-id><pub-id pub-id-type="pmcid">PMC3682834</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hajnal</surname><given-names>A</given-names></name><name name-style="western"><surname>Zharikov</surname><given-names>A</given-names></name><name name-style="western"><surname>Polston</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Alcohol reward is increased after Roux-en-Y gastric bypass in dietary obese rats with differential effects following ghrelin antagonism</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><issue>11</issue><fpage>e49121</fpage><pub-id pub-id-type="pmid">23145091</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0049121</pub-id><pub-id pub-id-type="pmcid">PMC3492295</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Hajnal A, Zharikov A, Polston JE et al (2012) Alcohol reward is increased after Roux-en-Y gastric bypass in dietary obese rats with differential effects following ghrelin antagonism. PLoS ONE 7(11):e49121 (<bold>J</bold>)<pub-id pub-id-type="pmid">23145091</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0049121</pub-id><pub-id pub-id-type="pmcid">PMC3492295</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sirohi</surname><given-names>S</given-names></name><name name-style="western"><surname>Richardson</surname><given-names>BD</given-names></name><name name-style="western"><surname>Lugo</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Impact of Roux-en-Y gastric bypass surgery on appetite, alcohol intake behaviors, and midbrain ghrelin signaling in the rat</article-title><source>Obesity</source><year>2017</year><volume>25</volume><issue>7</issue><fpage>1228</fpage><lpage>1236</lpage><pub-id pub-id-type="pmid">28500684</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/oby.21839</pub-id><pub-id pub-id-type="pmcid">PMC6029700</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Sirohi S, Richardson BD, Lugo JM et al (2017) Impact of Roux-en-Y gastric bypass surgery on appetite, alcohol intake behaviors, and midbrain ghrelin signaling in the rat. Obesity 25(7):1228&#8211;1236 (<bold>J</bold>)<pub-id pub-id-type="pmid">28500684</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/oby.21839</pub-id><pub-id pub-id-type="pmcid">PMC6029700</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Courcoulas</surname><given-names>AP</given-names></name><name name-style="western"><surname>Daigle</surname><given-names>CR</given-names></name><name name-style="western"><surname>Arterburn</surname><given-names>DE</given-names></name></person-group><article-title>Long term outcomes of metabolic/bariatric surgery in adults</article-title><source>BMJ</source><year>2023</year><volume>383</volume><fpage>e071027</fpage><pub-id pub-id-type="pmid">38110235</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj-2022-071027</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Courcoulas AP, Daigle CR, Arterburn DE (2023) Long term outcomes of metabolic/bariatric surgery in adults. BMJ 383:e071027 (<bold>J</bold>)<pub-id pub-id-type="pmid">38110235</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj-2022-071027</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiedemann</surname><given-names>AA</given-names></name><name name-style="western"><surname>Saules</surname><given-names>KK</given-names></name><name name-style="western"><surname>Ivezaj</surname><given-names>V</given-names></name></person-group><article-title>Emergence of new onset substance use disorders among post-metabolic bariatric surgery patients</article-title><source>Clin Obes</source><year>2013</year><volume>3</volume><issue>6</issue><fpage>194</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">25586736</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/cob.12034</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Wiedemann AA, Saules KK, Ivezaj V (2013) Emergence of new onset substance use disorders among post-metabolic bariatric surgery patients. Clin Obes 3(6):194&#8211;201 (<bold>J</bold>)<pub-id pub-id-type="pmid">25586736</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/cob.12034</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ivezaj</surname><given-names>V</given-names></name><name name-style="western"><surname>Saules</surname><given-names>KK</given-names></name><name name-style="western"><surname>Wiedemann</surname><given-names>AA</given-names></name></person-group><article-title>&#8220;I didn&#8217;t see this coming&#8221;: why are postbariatric patients in substance abuse treatment? Patients&#8217; perceptions of etiology and future recommendations</article-title><source>Obes Surg</source><year>2012</year><volume>22</volume><issue>8</issue><fpage>1308</fpage><lpage>1314</lpage><pub-id pub-id-type="pmid">22661046</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11695-012-0668-2</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Ivezaj V, Saules KK, Wiedemann AA (2012) &#8220;I didn&#8217;t see this coming&#8221;: why are postbariatric patients in substance abuse treatment? Patients&#8217; perceptions of etiology and future recommendations. Obes Surg 22(8):1308&#8211;1314<pub-id pub-id-type="pmid">22661046</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11695-012-0668-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Er</surname><given-names>E</given-names></name><name name-style="western"><surname>Flahault</surname><given-names>C</given-names></name><name name-style="western"><surname>Etienne</surname><given-names>AM</given-names></name></person-group><article-title>'We're outside the norm again because of the thing that allowed us to be inside the norm': An interpretative phenomenological analysis of the experience of developing an alcohol use disorder after bariatric surgery</article-title><source>Clin Obes</source><year>2024</year><volume>14</volume><issue>2</issue><fpage>e12630</fpage><pub-id pub-id-type="pmid">38036451</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/cob.12630</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Er E, Flahault C, Etienne AM (2024) &#8220;We&#8217;re outside the norm again because of the thing that allowed us to be inside the norm&#8221;: An interpretative phenomenological analysis of the experience of developing an alcohol use disorder after bariatric surgery. Clin Obes 14(2):e12630 (<bold>J</bold>)<pub-id pub-id-type="pmid">38036451</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/cob.12630</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J</given-names></name><name name-style="western"><surname>Nemati</surname><given-names>R</given-names></name><etal/></person-group><article-title>Acute changes of bile acids and FGF19 after sleeve gastrectomy and Roux-en-Y gastric bypass</article-title><source>Obes Surg</source><year>2019</year><volume>29</volume><issue>11</issue><fpage>3605</fpage><lpage>3621</lpage><pub-id pub-id-type="pmid">31273649</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11695-019-04040-x</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Chen Y, Lu J, Nemati R et al (2019) Acute changes of bile acids and FGF19 after sleeve gastrectomy and Roux-en-Y gastric bypass. Obes Surg 29(11):3605&#8211;3621 (<bold>J</bold>)<pub-id pub-id-type="pmid">31273649</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11695-019-04040-x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skibicka</surname><given-names>KP</given-names></name><name name-style="western"><surname>Hansson</surname><given-names>C</given-names></name><name name-style="western"><surname>Alvarez-Crespo</surname><given-names>M</given-names></name><etal/></person-group><article-title>Ghrelin directly targets the ventral tegmental area to increase food motivation</article-title><source>Neuroscience</source><year>2011</year><volume>180</volume><fpage>129</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">21335062</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuroscience.2011.02.016</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Skibicka KP, Hansson C, Alvarez-Crespo M et al (2011) Ghrelin directly targets the ventral tegmental area to increase food motivation. Neuroscience 180:129&#8211;137 (<bold>J</bold>)<pub-id pub-id-type="pmid">21335062</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuroscience.2011.02.016</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jerlhag</surname><given-names>E</given-names></name><name name-style="western"><surname>Egecioglu</surname><given-names>E</given-names></name><name name-style="western"><surname>Landgren</surname><given-names>S</given-names></name><etal/></person-group><article-title>Requirement of central ghrelin signaling for alcohol reward</article-title><source>Proc Natl Acad Sci USA</source><year>2009</year><volume>106</volume><issue>27</issue><fpage>11318</fpage><lpage>11323</lpage><pub-id pub-id-type="pmid">19564604</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0812809106</pub-id><pub-id pub-id-type="pmcid">PMC2703665</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">Jerlhag E, Egecioglu E, Landgren S et al (2009) Requirement of central ghrelin signaling for alcohol reward. Proc Natl Acad Sci USA 106(27):11318&#8211;11323 (<bold>J</bold>)<pub-id pub-id-type="pmid">19564604</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0812809106</pub-id><pub-id pub-id-type="pmcid">PMC2703665</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Landgren</surname><given-names>S</given-names></name><name name-style="western"><surname>Simms</surname><given-names>JA</given-names></name><name name-style="western"><surname>Hyyti&#228;</surname><given-names>P</given-names></name><etal/></person-group><article-title>Ghrelin receptor (GHS-R1A) antagonism suppresses both operant alcohol self-administration and high alcohol consumption in rats</article-title><source>Addict Biol</source><year>2012</year><volume>17</volume><issue>1</issue><fpage>86</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">21309944</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1369-1600.2010.00280.x</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Landgren S, Simms JA, Hyyti&#228; P et al (2012) Ghrelin receptor (GHS-R1A) antagonism suppresses both operant alcohol self-administration and high alcohol consumption in rats. Addict Biol 17(1):86&#8211;94 (<bold>J</bold>)<pub-id pub-id-type="pmid">21309944</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1369-1600.2010.00280.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davis</surname><given-names>JF</given-names></name><name name-style="western"><surname>Schurdak</surname><given-names>JD</given-names></name><name name-style="western"><surname>Magrisso</surname><given-names>IJ</given-names></name><etal/></person-group><article-title>Gastric bypass surgery attenuates ethanol consumption in ethanol-preferring rats</article-title><source>Biol Psychiatry</source><year>2012</year><volume>72</volume><issue>5</issue><fpage>354</fpage><lpage>360</lpage><pub-id pub-id-type="pmid">22444202</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopsych.2012.01.035</pub-id></element-citation><mixed-citation id="mc-CR62" publication-type="journal">Davis JF, Schurdak JD, Magrisso IJ et al (2012) Gastric bypass surgery attenuates ethanol consumption in ethanol-preferring rats. Biol Psychiatry 72(5):354&#8211;360 (<bold>J</bold>)<pub-id pub-id-type="pmid">22444202</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopsych.2012.01.035</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shirazi</surname><given-names>RH</given-names></name><name name-style="western"><surname>Dickson</surname><given-names>SL</given-names></name><name name-style="western"><surname>Skibicka</surname><given-names>KP</given-names></name></person-group><article-title>Gut peptide GLP-1 and its analogue, Exendin-4, decrease alcohol intake and reward</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><issue>4</issue><fpage>e61965</fpage><pub-id pub-id-type="pmid">23613987</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0061965</pub-id><pub-id pub-id-type="pmcid">PMC3628574</pub-id></element-citation><mixed-citation id="mc-CR63" publication-type="journal">Shirazi RH, Dickson SL, Skibicka KP (2013) Gut peptide GLP-1 and its analogue, Exendin-4, decrease alcohol intake and reward. PLoS ONE 8(4):e61965 (<bold>J</bold>)<pub-id pub-id-type="pmid">23613987</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0061965</pub-id><pub-id pub-id-type="pmcid">PMC3628574</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jerlhag</surname><given-names>E</given-names></name></person-group><article-title>Alcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1</article-title><source>Brain Res</source><year>2020</year><volume>1727</volume><fpage>146562</fpage><pub-id pub-id-type="pmid">31759971</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.brainres.2019.146562</pub-id></element-citation><mixed-citation id="mc-CR64" publication-type="journal">Jerlhag E (2020) Alcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1. Brain Res 1727:146562 (<bold>J</bold>)<pub-id pub-id-type="pmid">31759971</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.brainres.2019.146562</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>